Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Share News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Footsie gives up gains

Mon, 11th Jan 2010 16:41

The leading share index gave up early gains to finish only slightly higher as euphoria over strong trade figures from China in December gave way to renewed fears over recovery prospects. China's December imports jumped by 55.9% from the same month the previous year, while exports were 17.7% higher. Continued demand for commodities was behind much of the rise, with crude oil imports climbing 25% and copper imports up by more than a quarter.Oil company Cairn Energy was a strong performer after positive noises from Citigroup. The broker says that fast-tracking the multi-well exploration drilling programme in Greenland has made the group its preferred play on frontier exploration in 2010. Dana is its value play while Tullow could be the most exciting story over the first quarter.Elsewhere in the sector, BP and Shell advanced as oil hit a 15-month high.But miners, which had been among the top risers after the Chinese data came out, gave up these gains in afternoon trading. Silver miner Fresnillo slipped back after it dropped out of the race for Canadian mining company Canplats Resources. Eurasian Natural Resources, Vedanta Resources, Anglo American and Xstrata also closed lower.Bank Barclays has received its third upbeat broker note in less than a week. This time it is Citigroup that reckons the bank is cheap, adding that the market is applying too low a rating to Barclays' earnings. Citigroup's target price is 413p, implying 30% upside.Property groups Land Securities and British Land climbed after the former was added to Goldman Sachs' 'conviction buy' list. Segro, which updated on trading today, rose after Goldman upgraded its rating on the stock to 'neutral'. Inès Reinman, Segro's head of Continental Europe, has resigned from the industrial property group barely a year she was promoted to the board. "Current trading and market conditions are in line with our expectations at the time of our Interim Management Statement issued on 5 November 2009," chief executive Ian Coull added.SABMiller fell after it pulled out of the race to buy the Femsa stable of beer brands leaving the way clear for rival brewer Heineken.Cash strapped plumbers merchant Wolseley is to raise just under £24m from the sale of its Irish businesses. WIBHM, a company backed by private investor, is paying €26.5m for Wolseley Ireland Holdings Limited. The exceptional loss on disposal, excluding currency impacts, is expected to be around €55m (£50m).Online gaming group PartyGaming has tied up an an exclusive, five-year agreement with state-controlled Danske Spil to provide an online gaming platform for poker and casino games in Denmark. Outdoor clothing retailer Blacks Leisure said it is mulling a possible equity fundraising in the first quarter to raise between £15m and £20m depending on investor demand. It hopes to roll out new stores, having closed 87 loss-making outlets in the fourth quarter of 2009. It said trading in the ongoing stores was very healthy with like-for-like sales increasing by 12.0% in the half year ended 7 JanuaryThe US Navy has awarded defence and aerospace group Cobham a contract worth up to $11.5m for the UK group. Cobham has won the Band 5/6 TWT (Travelling-wave Tube) Replacement Module Assembly (TRMA) development contract.Stem cell therapy group ReNeuron said it is on track to start human trials of its flagship treatment ReN001 for disabled stroke patients in the first quarter of this year.EMED Mining's quest to reopen the Rio Tinto mine in Spain moved a step closer following recent court rulings deemed favourable to the company. The cases all related to objections by previous stakeholders in the mine.FTSE 100 - RisersLand Securities Group (LAND) 683.00p +2.86%TUI Travel (TT.) 271.00p +2.69%British Land Co (BLND) 473.40p +2.60%BG Group (BG.) 1,223.00p +2.43%Marks & Spencer Group (MKS) 375.00p +2.35%Cairn Energy (CNE) 370.30p +2.32%Kingfisher (KGF) 230.80p +2.30%BP (BP.) 635.50p +2.22%SEGRO (SGRO) 350.70p +1.95%Morrison (Wm) Supermarkets (MRW) 290.20p +1.90%FTSE 100 - FallersEurasian Natural Resources (ENRC) 1,010.00p -2.32%Standard Chartered (STAN) 1,590.00p -2.09%Legal & General Group (LGEN) 82.55p -2.08%SABMiller (SAB) 1,801.00p -2.01%Prudential (PRU) 626.50p -1.88%Man Group (EMG) 314.00p -1.81%Vedanta Resources (VED) 2,834.00p -1.80%Anglo American (AAL) 2,845.00p -1.79%Xstrata (XTA) 1,224.50p -1.76%Fresnillo (FRES) 852.00p -1.62%FTSE 250 - RisersRenishaw (RSW) 602.00p +5.61%St James's Place (STJ) 270.00p +5.47%Electra Private Equity (ELTA) 1,280.00p +5.09%Interserve (IRV) 229.90p +5.07%Lamprell (LAM) 211.00p +4.87%BlueBay Asset Management (BBAY) 347.40p +4.48%Halfords Group (HFD) 436.00p +4.31%Dechra Pharmaceuticals (DPH) 493.00p +4.23%Telecity Group (TCY) 424.00p +3.95%Domino Printing (DNO) 353.60p +3.66%FTSE 250 - FallersImagination Technologies (IMG) 262.80p -5.81%Weir Group (WEIR) 798.00p -4.09%Carphone Warehouse Group (CPW) 192.20p -2.88%Close Brothers Group (CBG) 712.00p -2.40%Unite Group (UTG) 289.10p -2.36%Barratt Developments (BDEV) 138.70p -2.26%Charter International (CHTR) 770.00p -2.10%SIG (SHI) 122.80p -1.92%DS Smith (SMDS) 125.70p -1.80%Investec (INVP) 454.80p -1.69%
More News
15 Apr 2014 12:23

ReNeuron leases building for relocation of business

AIM-listed ReNeuron has signed a deal with the Welsh government to lease a landmark building at Pencoed Technology Park, near Cardiff in South Wales. The stem cell therapy company explained that it will build a new state-of-the-art facility at Pencoed, to which it will relocate the business next ye

Read more
15 Apr 2014 10:01

ReNeuron Leases New Research & Development Facility With Welsh Government

LONDON (Alliance News) - Stem cell therapy company ReNeuron Group PLC said Tuesday that it had signed an agreement with the Welsh Government to lease a new research and development facility at the Pencoed Technology Park near Cardiff, South Wales. ReNeuron expects to begin to relocate its o

Read more
15 Apr 2014 07:50

UK MORNING BRIEFING: Aggreko Leads After Mixed Results

LONDON (Alliance News) - Aggreko is leading the FTSE 100 in early trading Tuesday after the temporary power company said it has seen mixed results in its first quarter, with strong underlying revenue growth in two of its three regions being impacted by adverse currency movements as previously exp

Read more
27 Mar 2014 13:48

UK MIDDAY BRIEFING: Regulators Confirm UK Energy Market Review

LONDON (Alliance News) - UK regulators have now confirmed they will investigate whether the country's major energy companies are preventing effective competition in the market, a decision that prompted British Gas parent Centrica to warn that the review could delay crucial investments in new i

Read more
27 Mar 2014 13:01

UK WINNERS & LOSERS: Babcock, Tullow Oil Lead Blue-Chip Fallers

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.

-------

FTSE 100 - WINNERS

Old Mutual, up 0.5%. The group has agreed to sell Skandia Germany and S

Read more
27 Mar 2014 11:13

ReNeuron Gets Approvals To Begin Two New Trials Using Stem Cell Product

LONDON (Alliance News) - ReNeuron Group PLC said Thursday that it has received final regulatory and ethical approvals to begin two new clinical trials using its CTXcyro stem cell product. The company will begin a Phase II clinical trial of its ReN001 investigational therapy in stroke disabi

Read more
14 Mar 2014 13:04

ReNeuron Eyes New UK Government Scheme Encouraging Novel Therapies

LONDON (Alliance News) - ReNeuron Group PLC Friday said it will look at whether the UK government's plan to launch a scheme to encourage the take up of novel therapies could be applied to its own therapeutic candidates. The scheme, called the Early Access to Medicines Scheme, is looking to

Read more
11 Mar 2014 12:48

US foundation funds ReNeuron stem cell therapy

A US-based charity has agreed to provide funding and access to clinical expertise for ReNeuron's retinal stem cell therapy candidate for a degenerative eye disease. Shares in ReNeuron rose 8.8% to 3.54p on the news. The Foundation for Fighting Blindess has agreed to provide further funding toward

Read more
11 Mar 2014 11:27

ReNeuron Retinal Stem Cell System Wins FFB Support

LONDON (Alliance News) - ReNeuron Group PLC said Tuesday its retinal stem cell therapy candidate is to receive support from a retinal research funding foundation. ReNeuron said its ReN003 retinal stem cell therapy candidate for the treatment of retinis pigmentosa is set to receive support

Read more
21 Jan 2014 10:04

ReNeuron Sees Positive Data For Stem Cells In Retinal Degeneration Test

LONDON (Alliance News) - ReNeuron Group PLC said Tuesday that a paper detailing the efficiency of its human retinal stem cells in a test model of retinal degeneration had been published in the Journal of Biological Chemistry. The test showed that ReNeuron's cells protected visual function w

Read more
21 Jan 2014 08:19

UK MORNING BRIEFING: Shares Higher; Unilever, SABMiller As Expected

LONDON (Alliance News) - UK shares have opened higher Tuesday, as Unilever and SABMiller have released results and trading statements in line with expectations.

Peel Hunt has issued ratings on the property sector, cutting Great Portland Est

Read more
13 Sep 2013 09:02

ReNeuron Moving All Therapeutic Programmes To Phase II Trials In Next 3 Years

Read more
22 Jul 2013 10:50

ReNeuron announces capital increase, funds to enter capital structure

Lifesciences group ReNeuron has announced that it has successfully raised 33m pounds in fresh funding to finance its research into stem-cell development, although it had to offer a small discount for the new equity. Significantly, three new investment funds are to enter its shareholder register with

Read more
28 May 2013 10:39

ReNeuron jumps on stem cell study results

Shares in AIM-listed stem cell business ReNeuron Group rose on Tuesday morning after the group unveiled details of progress with the PISCES clinical trial of its ReN001 stem cell therapy for disabled stroke patients. The group said that the primary aim of the study was to test the safety and toler

Read more
26 Mar 2013 09:45

ReNeuron Group to begin stem cell treatment of critical limb ischaemia

ReNeuron Group has received regulatory approval to begin the first phase of a clinical trial in the UK for the company's ReN009 stem cell therapy treatment for critical limb ischaemia. Critical limb ischaemia, a condition which leads to blood vessel blockage in limbs such as toes and can lead to am

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account